EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early Detection of Multiple Sclerosis Using Spectroscopic Epstein–Barr Virus Biosensors Based on Infection Mechanism Mimicry

Ülkü Anık iD, Nil Su Çaylayık

Analytical Chemistry · 2025

DOI: 10.1021/acs.analchem.5c03964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Ülkü Anık und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sensors, Biosensors and Nano-Diagnostic Systems Laboratory, Research Laboratory Center, Mugla Sitki Kocman University, Mugla 48000, Turkey. Hauptthemen laut MEDLINE: Biosensing Techniques, Multiple Sclerosis, Herpesvirus 4, Human, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The association between Epstein-Barr virus (EBV) and multiple sclerosis has made the asymptomatic detection of EBV very significant. In this study, a spectroscopic/colorimetric EBV biosensor was developed for practical and early screening by replicating the virus's natural infection mechanism. In order to accomplish this, gold nanoparticles (AuNPs) were functionalized with the B cell surface protein CD21, thereby mimicking the native host cell receptor. The interaction between CD21@AuNP and the EBV surface glycoprotein gp350 was then obtained spectroscopically through absorbance measurements, which was accompanied by a visible color change. Experimental parameters, including the incubation temperature and time, were systematically optimized to enhance the assay performance. Under optimized conditions, the biosensor exhibited a linear detection range of 10-100 ng/mL, with a limit of detection of 0.0279 ng/mL, a limit of quantification of 0.0848 ng/mL, and a relative standard deviation of 0.848%. Validation with 1:100 diluted saliva samples obtained from healthy volunteers further confirmed the sensor's high sensitivity and robustness, demonstrating its strong potential for translation into real-world diagnostic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesMultiple SclerosisHerpesvirus 4, HumanEpstein-Barr Virus InfectionsHumansGoldMetal NanoparticlesLimit of DetectionEarly DiagnosisSaliva

Substanzen

Gold

Autor:innen und Institutionen

  • Sensors, Biosensors and Nano-Diagnostic Systems Laboratory, Research Laboratory Center, Mugla Sitki Kocman University, Mugla 48000, Turkey.
  • Faculty of Science, Chemistry Department, Mugla Sitki Kocman University, Mugla 48000, Turkey.

ORCID-Profile: Ülkü Anık

Zitieren

APA

Anık, Ü., & Çaylayık, N. S. (2025). Early Detection of Multiple Sclerosis Using Spectroscopic Epstein–Barr Virus Biosensors Based on Infection Mechanism Mimicry. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c03964

Vancouver

Anık Ü, Çaylayık NS. Early Detection of Multiple Sclerosis Using Spectroscopic Epstein–Barr Virus Biosensors Based on Infection Mechanism Mimicry. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c03964

BibTeX
@article{Ank2025,
  author = {Anık, Ülkü and Çaylayık, Nil Su},
  title = {Early Detection of Multiple Sclerosis Using Spectroscopic Epstein–Barr Virus Biosensors Based on Infection Mechanism Mimicry},
  journal = {Analytical Chemistry},
  year = {2025},
  doi = {10.1021/acs.analchem.5c03964}
}
Kostenlos starten →